Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells

Journal of Immunological Methods

Volumn 335, Issue 1-2, 2008, Pages 106-115

  Chaparro, Rodolfo José ^a   Burton, Amanda R ^b   Serreze, David V ^c   Vignali, Dario A A ^b   DiLorenzo, Teresa P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Antigen; CD8+ T cells; Diabetes; Epitope; Mimotope; NOD; Peptide library; Retrogenic

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE LIBRARY; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOLOGIC TECHNIQUES; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; PEPTIDE LIBRARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSFECTION;

MUS; MUS MUSCULUS;

EID: 43049173734     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.03.007     Document Type: Article

References (35)

1. + T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9311
2. Arnold P.Y., Burton A.R., and Vignali D.A. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. J. Immunol. 173 (2004) 3103
3. a donors. Diabetes 42 (1993) 44
4. Coligan J.E. Current Protocols in Immunology (1996), Wiley, New York
5. Crawford F., Huseby E., White J., Marrack P., and Kappler J.W. Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol. 2 (2004) E90
6. + T cells in NOD mice. Immunol. Rev. 204 (2005) 250
7. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., and Serreze D.V. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12538
8. + T-cell population comprises multiple antigenic specificities. Clin. Immunol. 105 (2002) 332
9. DiLorenzo T.P., Peakman M., and Roep B.O. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 148 (2007) 1
10. Graser R.T., DiLorenzo T.P., Wang F., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., and Serreze D.V. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164 (2000) 3913
11. Green W.R., Ballas Z.K., and Henney C.S. Studies on the mechanism of lymphocyte-mediated cytolysis. XI. The role of lectin in lectin-dependent cell-mediated cytotoxicity. J. Immunol. 121 (1978) 1566
12. Gundlach B.R., Wiesmuller K.H., Junt T., Kienle S., Jung G., and Walden P. Determination of T cell epitopes with random peptide libraries. J. Immunol. Methods 192 (1996) 149
13. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv. Immunol. 87 (2005) 123
14. Hedfors I.A., and Brinchmann J.E. Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R. Scand. J. Immunol. 58 (2003) 522
15. Holst J., Szymczak-Workman A.L., Vignali K.M., Burton A.R., Workman C.J., and Vignali D.A. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1 (2006) 406
16. Holst J., Vignali K.M., Burton A.R., and Vignali D.A. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat. Methods 3 (2006) 191
17. Houghten R.A., Pinilla C., Blondelle S.E., Appel J.R., Dooley C.T., and Cuervo J.H. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354 (1991) 84
18. Kao C., Daniels M.A., and Jameson S.C. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation. Int. Immunol. 17 (2005) 1607
19. Liblau R.S., Wong F.S., Mars L.T., and Santamaria P. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17 (2002) 1
20. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8384
21. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173 (2004) 6727
22. Martin S., and Bevan M.J. Transient alteration of T cell fine specificity by a strong primary stimulus correlates with T cell receptor down-regulation. Eur. J. Immunol. 28 (1998) 2991
23. Montes M., Rufer N., Appay V., Reynard S., Pittet M.J., Speiser D.E., Guillaume P., Cerottini J.C., Romero P., and Leyvraz S. Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy. Clin. Exp. Immunol. 142 (2005) 292
24. Purbhoo M.A., Irvine D.J., Huppa J.B., and Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 5 (2004) 524
25. + T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. J. Immunol. 154 (1995) 2494
26. null mice are diabetes and insulitis resistant. Diabetes 43 (1994) 505
27. null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164 (2000) 2496
28. Szymczak A.L., Workman C.J., Wang Y., Vignali K.M., Dilioglou S., Vanin E.F., and Vignali D.A. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22 (2004) 589
29. + T cell clonotype AI4. J. Immunol. 173 (2004) 2530
30. Tham E.L., and Mescher M.F. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness). J. Immunol. 169 (2002) 1822
31. Tisch R., and McDevitt H. Insulin-dependent diabetes mellitus. Cell 85 (1996) 291
32. + T cells in autoimmunity. Curr. Opin. Immunol. 17 (2005) 624
33. Wang Y., Rubtsov A., Heiser R., White J., Crawford F., Marrack P., and Kappler J.W. Using a baculovirus display library to identify MHC class I mimotopes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2476
34. Wicker L.S., Leiter E.H., Todd J.A., Renjilian R.J., Peterson E., Fischer P.A., Podolin P.L., Zijlstra M., Jaenisch R., and Peterson L.B. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43 (1994) 500
35. Wong F.S., Karttunen J., Dumont C., Wen L., Visintin I., Pilip I.M., Shastri N., Pamer E.G., and Janeway C.A.J. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5 (1999) 1026